Intravitreal Aflibercept for Macular Oedema Secondary to Cen
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
Purpose of this study is to report the visual and anatomic outcomes in eyes with macular oedema (MO) secondary to central retinal vein occlusion (CRVO) that were switched from either intravitreal bevacizumab or ranibizumab to intravitreal aflibercept.

https://www.nature.com/eye/journal/v30/n1/pdf/eye2015175a.pdf
Like
Comment
Share